The FDA Has Approved Olumiant for the Treatment of Alopecia Areata

On Monday, June 13,  the U.S. Food and Drug Administration announced its approval of Eli Lilly’s oral tablet Olumiant (baricitinib) for the treatment of severe alopecia areata in adult patients. “Today’s action marks the first FDA approval of a systemic treatment (i.e. treats the entire body rather than a specific location) for alopecia areata,” the … Read more